SRx Health Solutions, Inc.
Financial highlights
| Metric | FY 09/30/25 | FY 07/07/25 | FY 12/31/24 | FY 09/30/24 | FY 12/31/23 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $6.5M | — | $35.0M | — | $38.6M |
| Cost of revenue | $5.0M | — | $22.0M | — | $26.8M |
| Gross profit | $1.5M | — | $13.0M | — | $11.8M |
| Selling, general & administrative | $12.9M | — | $19.0M | — | $24.4M |
| Research and development | — | — | $100,000 | — | $100,000 |
| Operating expenses | $12.9M | — | $19.0M | — | $33.0M |
| Operating income | -$11.4M | — | -$6.0M | — | -$21.2M |
| Interest expense | $628,000 | — | $467,000 | — | $1.4M |
| Pretax income | -$8.6M | — | -$159,000 | — | -$22.8M |
| Income tax expense | — | — | $9,000 | — | $2,000 |
| Net income | -$45.0M | — | -$168,000 | -$43.1M | -$22.8M |
| Balance Sheet | |||||
| Cash and equivalents | $1.3M | — | $3.1M | $106,000 | $4.5M |
| Current assets | $8.1M | — | $15.0M | $13.6M | $16.2M |
| Total assets | $8.4M | — | $15.8M | $33.8M | $16.7M |
| Current liabilities | $3.5M | — | $7.1M | $81.3M | $13.7M |
| Total liabilities | $8.0M | — | $7.2M | $88.9M | $13.8M |
| Total debt | $4.5M | $5.7M | — | $5.7M | $4.6M |
| Stockholders' equity | $407,000 | — | $8.6M | -$55.1M | $3.0M |
| Cash Flow Statement | |||||
| Cash from operations | -$8.1M | — | -$4.4M | -$1.5M | $97,000 |
| Depreciation and amortization | $100,000 | — | $100,000 | $4.4M | $200,000 |
| Stock-based compensation | $3.2M | — | $833,000 | $3.7M | $1.8M |
| Capital expenditure | — | — | $41,000 | — | $18,000 |
| Free cash flow | — | — | -$4.4M | — | $79,000 |
| Share repurchases | $137,000 | — | $206,000 | — | — |
| Impairments | — | — | — | $19.7M | $8.5M |
Shares outstanding 590.3M · Free float 81.7%
Annual filing data through FY ended September 30, 2025; float as of July 13, 2026.